Left ventricular function immediately after intravenous cocaine: A quantitative two-dimensional echocardiographic study  by Eisenberg, Mark J. et al.
JACC Vol. 22, No . 6
November 15,19931081-6
1581
COCAINE EFFECTS
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A Quantitative Two-DimenZ* anal Echocardiographic Study
MARK J . EISENBERG, MD, MPH, JOHN MENDELSON, MD, G. THOMAS EVANS, JR., MD,
JOHN JUE, MD, FRCP(C) FACC, REESE T . JONES, MD, NELSON B . SCHILLER, MD, FACC
San Francisco, Calitbrnia
Objectives . We tested the hypothesis that intravenous cocaine,
in doses commonly self-administered in nonmedical settings,
causes acute myocardial ischemin and left ventricular dysfunction .
Back-groand. Cocaine-Induced cardiac complications are re-
sponsible for a growing number of deaths in young people, but the
mechanism by which cocaine induces these complications Is un-
clear .
Methods . We performed 12-lead electrocardiography and
quantitative two-dimensional echocardiography in 20 subjects
before and after single intravenous doses of high dose cocaine
(1.2 mg/kg body weight), low dose cocaine (0 .6 mglkg) and
placebo .
Results . At 2 to 7 min after cocaine administration, the
rate-pressure product was increased significantly from baseline
(high dose 73%, low dose 63%, placebo 8%, p < 0.001 for either
dose vs. placebo). During this time, electrocardiography demon-
strated dose-related nonspecific changes (high dose in 14 of 20
Self-administered cocaine is responsible for a growing
number of deaths in young people . These deaths are often
caused by cocaine-induced cardiac complications, including
myocardial infarction, congestive heart failure, ventricular
arrhythmias and sudden death (1-3) . Although these cardiac
complications have been temporally related to cocaine use,
little is known about the mechanisms by which they occur .
Three mechanisms have been proposed : 1) a cocaine-
induced mismatch between myocardial oxygen supply and
demand; 2) a direct myocardial depressant effect of cocaine ;
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subjects, low dose in 9 of 20 subjects, placebo in 2 of 20 subjects,
p < 0.002 for either dose vs. placebo) . In contrast, echocardiog-
raphy showed that the frequency of hyperdynamic left ventricular
wall segments doubled after high dose cocaine compared with
placebo (34% 1108 of 3181 vs . 16% 151 of 319), respectively, p =
0.0001) but that there was no change in either left ventricular
ejection fraction (high dose 66 ± 9%, placebo 67 ± 6%, p = NS)
or wall motion score index (high dose 0 .67 ± 0.44, placebo 0 .85
0,30, p = NS) .
Conclusions . We conclude that Intravenous cocalne, in doses
commonly self-administered in nonmedical settings, does not
cause acute myocardial ischemia or left ventricular dysfunction .
We speculate that cocaine-induced cardiac complications are
caused by idiosyncratic coronary artery vasospasm, by exception .
ally high dosages or by cocaine-induced coronary artery throm-
bosis .
(J Am Coll Cardiol 1993,22
:1581-6)
and 3) a prothrombotic effect . The mismatch theory is
supported by a variety of human and animal studies that
demonstrate a cocaine-induced reduction in myocardial oxy-
gen supply (4,5) accompanied by a simultaneous increase in
myocardial oxygen demand (6,7) . The myocardial depres-
sant theory is supported by a number of animal studies
demonstrating left ventricular dysfunction immediately after
intravenous cocaine administration (8-10) . The prothrom-
botic theory is supported by several in vitro studies (11,12)
that demonstrate cocaine-induced platelet aggregation .
Which of these three mechanisms is responsible for
cocaine-induced cardiac complications may be clarified by
examining the temporal relations between cocaine adminis-
tration and the occurrence of myocardial ischemia and left
ventricular dysfunction . Consequently, we performed 12-
lead electrocardiography and quantitative echocardiography
in 20 subjects who received single doses of intravenous
cocaine and placebo
. Twelve-lead electrocardiography was
used to monitor for myocardial ischemia, and two-
dimensional echocardiography was used to monitor for both
myocardial ischemia and left ventricular dysfunction. Our
purpose was to test the hypothesis that intravenous cocaine,
in doses commonly self-administered in nonmedical settings,
causes acute myocardial ischemia and left ventricular dys-
function .
0735-1097/9346-00
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Methods
Study patients . Twenty subjects (16 men, 4 women) were
recruited as paid volunteers . Subjects were cocaine users
between the ages of 20 and 40 years who had no evidence of
cardiac, neurologic, systemic or psychiatric illness . Subjects
reported cocaine use for an average of 14 years before the
study. In the year before the study, all subjects used
intravenous cocaine (average 1.9 times/week), and most
used a number of other illicit substances as well as alcohol
(average 3 times/week) and tobacco (average 14 cigarettes/
day). Subjects were screened with a comprehensive history,
physical and laboratory examinations (including human im-
munodeficiency virus testing) . Human immunodeficiency
virus-positive subjects and pregnant women were excluded
from the study . All subjects gave written informed consent
following the guidelines set forth by the Committee on
Human Research at the University of California, San Fran-
cisco .
Protocol . Each subject was studied on 3 separate days at
least 1 week apart. Subjects were asked not to use cocaine
for the 24 h before each laboratory session and not to use
tobacco or caffeine on the day of the study . Each study day,
subjects received either high dose cocaine (1 .2 mg/kg body
weight) infused intravenously for 2 min, low dose cocaine
(0.6 mg/kg) infused for I min or saline solution placebo
infused for 1 min. Subjects had physiologic variables moni-
tored for a minimum of 30 min before infusions (baseline)
and for at least 3 h afterward . The electrocardiograms
(ECGs) were recorded at baseline and at 2, 5, 10, i .5 and
180 min after infusion. Echocardiograms were recorded at
baseline and between 2 and 7 min after infusion. Blood
samples were obtained from an indwelling venous catheter in
the right arm at baseline and at 2, 10, 15 and 180 min after
infusion, Blood samples were frozen, and plasma cocaine
^id' benzoylccgonine concentrations were later measured by
gas chromatography (13).
Cocaine and Placebo administration. Cocaine hydrochlo-
ride was administered in normal saline solution in a concen-
tration of 10 mg/ml. The order of infusions was determined
by a 3 x 3 Latin square design . Neither the subjects nor the
technicians were aware of the dose given on a particular day .
Infusions were given by an indwelling venous catheter in the
left forearm, and an infusion pump was used to ensure a
uniform rate of administration .
Monitoring. To examine the physiologic effects of co-
caine, the following variables were recorded : heart rate,
blood pressure, skin temperature, oxygen saturation and
intoxication ratings . Heart rate and blood pressure were
recorded with a Physio-Control VSM-2 patient monitor, skin
temperature with a thermistor taped to the distal index finger
of the right hand and oxygen saturation with a continuous
pulse oxirneter
. Intoxication ratings were reported by sub-
jects on 0 to 100. A value of 0 was equivalent to not
feeling,ua,,, r,j~
;ated at all, and a value of 100 was equivalent to
feeling the most intoxicated the subject had ever been after
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an intravenous dose of cocaine . Except for intoxication
ratings, all variables were recorded at baseline (four mea-
surements durirg >30 min before infusion), every minute for
15 min after infusion and then at 1, 2 and 3 h . Intoxication
ratings were obtained at baseline and at 1, 2, 5, 7, 10 and
15 min after infusion .
Electrocardiography . Electrocardiograms were recorded
with subjects in the left lateral decubitus position . All ECGs
were obtained with a Marquette Mac II electrocardiograph .
In some of the subjects, precordial leads had to be displaced
inferiorly to obtain simultaneous echocardiograms (generally
leads V2 to V5 ) . However, displaced leads remained in the
same position for all ECGs recorded on a particular study
day. Six ECGs were recorded on each study day (baseline
and 2, 5, 10, 15 and 180 min), and each ECG was given an
identification code from a list of random numbers . For
analysis, the six ECGs were chronologically ordered . Then,
these groups of six ECGs were put in random order and were
analyzed in a blinded manner. Each ECG received a general
interpretation as well as a careful comparison with the other
five ECGs in the group (to look for evidence of evolving
ischemic changes) . Particular care was taken in the analysis
of ST segment and T wave changes .
Echocardiography . Transthoracic echocardiograms were
obtained with subjects in the left lateral decubitus position .
All echocardiograms were obtained by the same sonogra-
pher using a Hewlett-Packard Sonos 1 I 11 . Either a 2 .5- or a
3.5-MHz transducer was used, depending on which gave the
best endocardial definition for a particular subject . For each
study, the parasternal long- and short-axis and apical two-
and four-chamber views were obtained . All echocardio-
grams were given identification codes from a list of random
numbers. Echocardiograms were recorded on 0 .5-in .
(1.27 cm) VHS videotape and were subsequently analyzed in
a blinded manner in random sequence .
Wall motion abnormalities were assessed by visually
evaluating wall motion and endocardial thickening of the
different left ventricular wall segments . A 16-segment model
of the left ventricle was used (14) . (Because there were 20
subjects, 320 left ventricular segments were evaluated .)
Each segment was graded for wall motion and endocardial
thickening on a scale of 0 to 3: 0 = hyperdynamic ; 1
normal; 2 = mildly hypokinetic; 3 = more severe wall
motion abnormality (severe hypokinetia, akinesia or dyski-
nesia). The wall motion score index was derived by averag-
ing the scores from all left ventricular segments that were
adequately visualized .
Left ventricular ejection fraction was calculated off-line
by digital quantitation of images recorded as cine loops from
videotape. Off-line analysis was accomplished using a com-
puterized analysis system (Cineview Plus, Freeland GTI) .
Left ventricular measurements were obtained from two- and
four-chamber views during both systole and diastole . To
obtain ejection fractions, measurements were repeated three
times and averaged .
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Table 1. Peak Intoxication Ratings and Peak Plasma
Concentrations of Cocaine and Benzoylecgonine
Values are presented as mean value t SD for 20 subjects .
Statistical analysis. Continuous data are presented as the
mean value ± I SD . The rate-pressure product was calcu-
lated by multiplying simultaneously obtained heart rate and
systolic blood pressure . Analysis of variance for repeated
measures was used to compare physiologic variables and
frequencies of ECG changes (comparing both cocaine doses
with placebo). Paired Student i tests were used to compare
left ventricular ejection fractions and wall motion score
index at 2 to 7 min after infusion (high dose cocaine vs .
place )_ For all comparisons, a two-tailed p value :5 0.05
was considered statistically significant .
Results
Dosages. Peak intoxication ratings and peak plasma lev-
els of cocaine and benzoylecgonine suggest that the dosages
used in this study are comparable to dosages commonly
self-administered in nonmedical settings (Table 1) (l5-18) .
Thus, 10 of the 20 subjects reported intoxication ratings >90
after high dose cocaine, and 6 of the 20 reported ratings 2t86
after low dose cocaine . In addition, the peak plasma con-
centration that we observed after high dose cocaine was
709 ng/ml (mean concentration for 20 subjects) . This con-
centration is greater than that seen in some postmortem
studies of people who died of cocaine-induced cardiac
Figure 1. Rate-pressure product (mm Hg x
beats/min) after intravenous cocaine and pla-
cebo. 0 = 1 .2 mg/kg; 0 = 0 .6 mg/kg; V =
placebo; ECG = electrocardiogram ; ECHO =
echocardiogram . Rate-pressure product in-
creased within 2 min of cocaine infusions, re-
mained elevated for at least 15 min and returned
to baseline by 2 h .
(1 .2 mglks)
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complications . These studies found blood concentrations of
cocaine as low as 100 rigirai in intravenous users and 600
ng/rO in nasal users (15) .
Physiologic effects. Within 2 min of the initiation of co-
caine infusions, heart rate and blood pressure increased (Fig.
1, Table 2) . Peak effects occurred within 2 to 3 min, persisted
for at least 15 min and returned to baseline by 2 h . At 2 to
7 min after cocaine, the rate-pressure product was increased
significantly from baseline (high dose 73%, low dose 63%,
placebo 8%, p < 0 .001 for either dose vs . placebo). During
this time, skin temperature decreased (reflecting cocaine-
induced peripheral vasoconstriction), and oxygen saturation
was unchanged (measurements always x°%%) .
Electrocardiographic effects . All ECGs were normal at
baseline. Several subjects had normal variant patterns, in-
cluding early repolarization and persistent right precordial
inverted T waves, No subjects developed ST segment ele-
vation or new Q waves after cocaine infusions, but 17 of the 20
subjects had transient ECG changes, including 15 subjects with
nonspecific T or R wave changes, or both, and 2 subjects with
ST segment depression in a single ECG lead. One subject with
PR segment prolongation was noted after cocaine, but no atrial
or ventricular arrhythmias were observed .
Fifteen subjects had nonspecific T or R wave changes, or
both, observed after cocaine infusion-. (high dose in 14 of 20,
low dose in 9 of 20, placebo in 2 of 20, p < 0 .002 for either
dose vs. placebo) . Each of the 15 subjects had increases or
decreases in T wave height associated with minor QRS axis
changes (reflecting changes iii the QRS-T angle) . In 5 of the
20 subjects, the T wave became inverted (in both limb and
precordial leads). and in 3 subjects, there was a transient loss
of R wave height in the right precordial leads .
One subject had ST segment depression that met standard
criteria for myocardial ischemia (1 .0 mm in lead V4
[mea-
sured 80 ms after the J point] with only minor PR segment
downsloping), and a second subject had only minor ST
segment depression (0.8 mm in lead
V4,
associated with T
wave inversion in leads 11, Ill and aVF) . Neither of these
Peak
Intoxication
Rating
(0 to 100)
Peak Cocaine
Concentration
(ng/ml)
Peak
Benzoylecgonme
Concentration
(ng/ml)
Placebo 3 t 8
Low dose cocaine
(0.6 mg/kg)
54 t 32 445 t 210 300 t 101
High dose cocaine 73 t 30 709 ± 255 484 ± 135
JACC Vol . 22. No . 6
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Table 2. Physiologic Changes After Cocaine and Placebo Infusions*
*Values presented are mean value ± SD for 20 subjects . ttlaseline values are an average of four measurements obtained over :230 min before i nfusion.
tp < 0.001 for either cocaine dose versus placebo (these were the only physiologic data compared statistically) .
subjects had left ventricular wall motion abnormalities ob-
served echocardiographically, suggesting that their ECG
changes were falsely positive for myocardial ischemia .
Echoc"ographic effects . During the 2 to 7 min after
high dose cocaine, the frequency of hyperdynamic left
ventricular wall segments doubled compared with placebo
(3496 [108 of 318] vs . 16% [51 of 319], respectively, p =
0.0001) (Table 3). No new wall motion abnormalities oc-
curred after high dose cocaine, and the number of left
ventricular wall segments with mild hypokinesia was un-
changed. In contrast, left ventricular ejection fraction and
left ventricular wall motion score index were the same after
both high dose cocaine and placebo (Table 3) . Because there
was little difference in the ejection fractions and wall motion
score indexes obtained after high dose cocaine and placebo,
the data obtained after low dose cocaine were visually
assessed but were riot quantitatively analyzed .
Advem effKh. No subject reported chest pain or dys-
pnea during the study. The only adverse event that occurred
was a panic attack that began within 5 min of high dose
cocaine administration . Symptoms included anxiety, hyper-
vigilance, delusional thinking and agitation, and they disap-
pealK in approximately 1 h with only supportive treatment
.
The subject refused to have physiologic measurements taken
at 6 to 7 min, at 9 to 15 min and at I h after infusion . He had
previously received low dose cocaine without incident .
Discussion
Our study tested the hypothesis that intravenous cocaine,
in doses commonly self-administered in nonmedical settings,
Table 3. Assessment of Left Ventricular Function by Quantitative
Echocardiography at 2 to 7 Minutes After High Dose Cocaine
and Placebo
*For each subject, wall motion abnormalities were scored by evaluating
16 different segments of the left ventricle
. Because there were 20 subjects, 320
left ventricular wall segments were evaluated after both high dose cocaine and
placebo
. tChi-square analysis, comparison of hyperdynamic left ventricular
wall segments versus all others. IPaired t test. Values presented are mean
value ± SD or number (%) of left ventricular segments
.
Minutes
Hours
Baselinet
2 to 7 8 to 15 1 2 3
Rate-pressure product (mm Hg x beats/win x 10')
Placebo
7 .5 ± lAt
7.9 ± Ln 7 .2 ± 1 .3 TI ± IA 7.6 ± 1 .5 8 .0 ± 1 .3
Cocaine
Low dose
7 .2 ± 1 .6* 11 .9 ± 2.4t 11.8±2.8
8.4±1 .5
71 ± 13
8.5±1.6
High dose
7.4 ± IN 12.6 ± 20
12.4±2.7 9.1±1 .6 8.2±1.7 &1 ± 1 .2
Heart rate (beats/min)
Placebo
69 ± 11 72 ± 13 68 ± 10 64 ± 10 67 ± It
71 ± 11
Cocaine
Low dose
66 ± 12
95 ± 19 98 1 20 70 ± 11 69± 10 73 ± 12
High doe
69 ± It 99±20
I0±20 74±12 70±11 70±9
Systolic blood pressure (mm Hg)
Placebo
108 ± 10
109 II 105 ± 10 Ill ± 10 113 ± 11 112 ± 9
Cocaine
Low dose
108 t 11 126 13 121 13
119 ± 8
115 1 II 117 ± 10
H10 dose 106 t 10
128 17 125 14 124 ± 14 118 ± 12 116 ± 10
Diastolic blood pressure (mm Hg)
Placebo
64 ± 8 61±9 59±9 71±7 70±9 65 ± 10
Cocaine
Low dose
64 t 8 72±10 69±9 75±8 72±10 69±7
High dose
63 ± 9 75®12 71±10 76±11 73±9 67±8
Chap in skin temperature from baseline (° C)
Placebo
-
-0.1 ± 1 .9
0 .4 ± 2 .1 1 .5 ± 2 .9 1 .2 ± 3 .4 1 .8 ± 3 .9
Cocaine
Low dose
-
-0.7 :t 1 .2 -0 .9 t 1 .6 -1 .6 t 2.9 1 .0 ± 4 .3 1 .8 ± 3 .6
High dose
-
-1.1 ± 1 .2 -li t 1 .4 -2.5 ± 3 .1 -LI t 2 .7 -0.8 ± 3 .2
Placebo
High Dose
Cocaine
(1 .2 mg/kg) p Value
Left ventricular wall motion* 0 .02t
Hyperdynamic 51(16) 108(34)
Normal 265 (83)
207 (65)
Mild hypokinesia 3 (<I) 3 (<I)
Severe hypokinesia/akinesia/ 0 (0)
0(0)
dyskinesia
Unreadable I (<0 2 (<I)
Total
320(100) 320(100)
Left ventricular ejection 67 ± 6 66 ± 9
NSt
fraction (lei)
Wall motion score index 0.85 ± 0 .30 0.67 ± 0.44
NSI
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causes acute myocardial ischemia and left ventricular dys-
function. Among the 20 subjects studied, we found no
evidence that intravenous cocaine caused either myocardial
ischemia or left ventricular dysfunction . Furthermore, we
found that the frequency of hyperdynamic left ventricular
wall segments doubled after high dose cocaine but that left
ventricular ejection fraction and wall motion score index
were unchanged despite an increase in rate-pressure prod-
uct. These results suggest that cocaine is a cardioactive
substance and that in doses :51 .2 mg/kg, cocaine actually
improves left ventricular function . From these results, we
conclude that intravenous cocaine, in doses commonly self
administered in nonmedical settings, does not cause acute
myocardial ischemia or left ventricular dysfunction .
Our results differ from those of previous studies, and they
provide little support for the mismatch or myocardial depres-
sant theories that have been proposed to explain cocaine-
induced cardiac complications . If cocaine causes a substan-
tial mismatch in myocardial oxygen supply and demand, we
should have observed both myocardial ischemia and left
ventricular dystunction . If cocaine has a direct myocardial
depressant effect, we should have observed left ventricular
dysfunction alone . Because we observed neither of these
effects, we speculate that cocaine-induced cardiac compli-
cations are caused by idiosyncratic coronary artery vaso-
spasm, by exceptionally high dosages of cocaine or by
cocaine-induced coronary artery thrombosis .
Myocardial ischernia . Most descriptions of cocaine-
induced myocardial ischeria have been based on ECGs
obtained during animal experiments or ECGs obtained from
individual patients who experienced chest pain after taking
cocaine (2,3,19,20) . These reports describe cocaine-induced
ECG changes that are indistinguishable from ischemic
changes due to coronary artery disease . Myocardial isch-
emia and myocardial infarction have been reported after
cocaine use, as have ischemia-related ventricular arrhyth-
mias and congestive heart failure (1-3) .
Despite previous reports of cocaine-induced myocardial
ischemia, we did not observe ischemic changes in the 20
subjects we studied . Serial ECGs showed that 15 subjects
had nonspecific T and R wave changes, and two subjects had
ST segment depression in 4 single lead . Among the nonspe-
cific ECG changes we observed, T wave abnormalities were
the most frequent. The most common cause of T wave
abnormalities is nonhomogeneous rcpolarization of the left
ventricle (21) . Characteristically, these changes affect only the
T wave and alter neither the course nor the duration of the ST
segment . In some situations, T wave abnormalities may reflect
myocardial ischemia, but changes similar to those we observed
may occur after tachycardia or catecholamine administration .
Because cocaine causes catecholamine-mediated tachycardia
and blood pressure elevation, we believe that the T wave
changes we observed are unlikely to be due to myocardial
ischemia. Our echocardiographic data support this idea, be-
cause we saw no evidence of new wall motion abnormalities in
the subjects with ECG changes (22,23) .
EISENBERG ET AL
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LA ventricular dysfunction, In contrast to previous re-
ports (8-10), we did not fend aiiy evidence of left ventricular
dysfunction immediately after intravenous cocaine . Two
factors may explain the differences between our findings and
those of previous studies
. First, although cocaine-induced
coronary artery vasoconstriction has been demonstrated in
previous studies, its magnitude is modest . Immediately after
cocaine administration, coronary artery diameter decreases
by an average of 8% to 12% in humans (4) and by 15% to 19%
in dogs (9,24) . Because cocaine causes only a modest
reduction in coronary artery diameter, this vasospastic effect
is unlikely to induce myocardial ischemia and left ventricular
dysfunction unless it is superimposed on an atherosclerotic
lesion or unless it occurs in conjunction with a pronounced
increase in myocardial oxygen demand. However, neither of
these factors is commonly observed . Normal coronary ar-
teries have been demonstrated in more than a third of the
angiographic studies of patients surviving cocaine-induced
myocardial infarctions (1,2,25) . in addition, although co-
caine clearly increases myocardial oxygen demand, our
results show that this effect is modest . At peak effect after
high dose cocaine, the average heart rate in our study
increased to 100 ± 20 beats/min, and the average systolic
blood pressure increased to 128 ± 17 min Hg . Thus, the
cocaine-induced mismatch between myocardial oxygen sup-
ply and demand is so modest that its likelihood of producing
myocardial ischemia in the typical user is low . This low
likelihood is supported by the fact that cocaine is used
frequently in the United States, yet comparatively few
cocaine-induced cardiac complications are reported (25) .
A second possible explanation for our not observing left
ventricular dysfunction after cocaine administration may be
the lower dosages that we used. In animal studies that
documented a direct myocardial depressant effect of co-
caine, dosages were 3 to 10 times the amount that we used
(8-40). However, our results suggest that these dosages are
substantially higher than the dosages commonly self-
administered in nonmedical settings . In fact, many of our
subjects reported that the high dose of cocaine we adminis-
tered was the most they would consider taking without
concern about adverse effects . Thus, our results suggest that
the mismatch and myocardial depressant theories are un-
likely explanations for many of the cocaine-induced cardiac
complications that are seen .
Study limitations. Two potential limitations of our study
should be noted . 1) Cocaine users often take multiple doses
over the course of many hours . Although our single dose of
cocaine was similar to dosages commonly self-administered
by users, cumulative blood levels in nonmedical settings
may be higher than those observed in our study, and these
high levels may be responsible for some cocaine-induced
cardiac complications . Nevertheless, cardiac complications
have been reported after single, small doses of cocaine (16) .
so a direct myocardial depressant effect is unlikely to be the
explanation for most cocaine-induced cardiac complications .
2) We only examined the immediate period (between 2
1596
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and 7 min) after cocaine administration . It is possible that
coo nine only produces its cardiac complications in the later
(subacute) period (i .e
., later than 7 min) and that we missed
&aumenting these deleterious effects . However, intrave-
nous cocaine has its peak hemodynamic effects in the time
period that we examined, and previous studies documented
both coronary artery vasoconstriction and left ventricular
dysfunction immediately after intravenous cocaine . If the
deleterious effects of cocaine are found to occur in the
subacute period, this evidence will further militate against
the mismatch and direct myocardial depressant theories .
Colndusllons. In summary, 1 .2 mg/kg of intravenous co-
caine did not cause acute myocardial ischemia or left ven-
tricular dysfunction in the 20 subjects we studied . Instead,
this dose appeared to improve left ventricular function .
From these results, we speculate that cocaine-induced car-
diac complications are caused by idiosyncratic coronary
artery vasospasm, by exceptionally high dosages or by
cocaine-induced coronary artery thrombosis . Readers
should not be falsely reassured by our findings . In addition to
numerous reports documenting the acute cardiac effects of
cocaine, several studies suggest that cocaine causes chronic
left ventricular dysfunction as well (26-28) . Given cocaine's
addictive qualities and its acute and chronic cardiac effects,
it is clear that, in some situations, cocaine can cause serious
and potentially life-threatening medical complications .
We are indebted to Mimi Zeiger for editorial advice, to Kayc Welch for
editorial assistance and to the following research assistants for help in data
collection
: James Brown, Mci Chow, Bob Jimison, Evan Lewis, Catherine
Ktumpp, Tina Melby, David Naimic,
Peter Shwonck and Eileen Tisdale .
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